НовостиBenzingaHC Wainwright & Co. Maintains Buy on Crescent Biopharma, Raises Price Target to $40 HC Wainwright & Co. Maintains Buy on Crescent Biopharma, Raises Price Target to $40 Benzinga 2026.11.13 12:38 (GMT+0) Открыть на Benzinga Другие новости